Dublin, Feb. 26, 2018 -- The "US HIV/AIDS Diagnostics Market Shares and Segment Forecasts 2017-2021: Emerging Opportunities and Growth Strategies for Suppliers" report has been added to ResearchAndMarkets.com's offering
This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIV Ag/HIV NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:
- Hospitals
- Commercial/Private Laboratories
- Blood Banks
- Physician Offices
- Public Health Laboratories
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.
Highlights
- Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
- Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
- Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho-Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
- Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
- Analyzes alternative market penetration strategies for suppliers.
Key Topics Covered:
I. Introduction
II. AIDS/HIV Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests: HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. USA: Market Size, Growth and Major Suppliers'
Sales and Market Shares
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatch/Leica
- Life Technology
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako
For more information about this report visit https://www.researchandmarkets.com/research/x6489j/us_hivaids?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Disease Testing


Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
DeepSeek to Raise AI API Prices as Demand for New Models Surges
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Shein Scales Back Vietnam Operations as US Trade Rules Shift
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
OpenAI Restricts Astra AI Over Cyberattack Risks 



